Skip to content
Abierto
Menu

Combined synopsis and solicitation

Amendment 001_Synthesis Services for Custom Biomolecules for Detection of Mutation-Reactive T cells in Patients With Metastatic Cancers

75N91024Q00094

National Institutes of Health, NIH NCI. Medical Laboratories.

View on SAM.govMarkdown

Awarded

Genscript USA Inc.

$2,052,000.00 obligated so far on USAspending

Description

As published on SAM.gov.

The purpose of Amendment 001 is to attach PDF "52.212-3(MAY2024)_FullText." Response date remains unchanged.

Please read the attached documents

The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research (CCR), Surgery Branch (SB) requires synthesis services for custom biomolecules for the detection of Mutation-Reactive T cells in patients with Metastatic Cancers.

This is a Combined Synopsis/Solicitation for commercial items, prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, as supplemented with additional information included in this notice, and shall be processed in accordance with FAR 13.5 - Simplified Procedures for Certain Commercial Products and Commercial Services. This announcement constitutes the only solicitation that will be provided in relation to the stated need contained herein.

This solicitation is issued as a Request for Quote (RFQ) and includes applicable provisions and clauses in effect through FAR Federal Acquisition Circular (FAC) 2024-05 (05/22/2024). One firm fixed priced award is anticipated to be made as a result of this solicitation. Please submit questions concerning this RFQ via email no later than 12:00PM EDT on Thursday, 08/08/2024. Quotes in response to this RFQ must be submitted via email no later than 6:00PM EDT on Monday, 08/12/2024.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Genscript USA Inc.
UEI
KVLBRRAQ6UX1
CAGE
5THB5
Vendor location
Piscataway, NJ
Contract
75N91024P00630, purchase order
Obligated
$2,052,000.00, potential $3,078,000
Actions
2 between September 6, 2024 and September 23, 2025
Competition
Competed Under SAP, 2 offers received
Set-aside reported
No Set Aside Used.
Described as
Synthesis Services for Custom Biomolecules (Gene Constructs and Peptides) in Support of National Institutes of Health (Nih), National Cancer Institute (Nci), Center for Cancer Research (Ccr), Surgery Branch (Sb)
Match
solicitation number 75N91024Q00094 equals the FPDS solicitation identifier; same awarding office 75N910 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. August 6, 2024

    Combined synopsis and solicitation

    Synthesis Services for Custom Biomolecules for Detection of Mutation-Reactive T cells in Patients With Metastatic Cancers

    Due August 12, 2024 at 6:00 PM EDT. SAM.gov, notice b0a7367eb95c482fb16ae7fb531617f5

  2. August 7, 2024

    Combined synopsis and solicitation

    Due August 12, 2024 at 6:00 PM EDT. SAM.gov, notice d4a89274ddfa4531b5a29fc69d067298

Points of contact

Also open from this buyer